ENGN

enGene TherapeuticsB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-21

View Chart

RSI (14)

48.3

Neutral

MACD Hist

0.05

Bullish

ATR (14)

0.09

Normal

Vol Z (20)

-1.57

Normal

RET 20D

+12.9%

Positive

Dist 52W High

-84.1%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-07-21

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Mixed trend (SMAs not aligned)

Momentum

Short-term rebound vs weak 3M trend · 20D +12.9% · 60D -75.8%

RSI / MACD

RSI 48.3 (Neutral) · MACD hist +0.05

Volatility

Volatility muted (Z -1.57)

SMA20

1.84

SMA50

1.74

SMA200

6.64

EMA12

1.87

EMA26

1.94

BB Upper

1.98

BB Mid

1.84

BB Lower

1.69

RET 5D

+1.6%

RET 20D

+12.9%

RET 60D

-75.8%

RET 120D

-81.1%

As of 2026-07-21 • Updated nightlySource: Internal modelMethodology